← Leaderboards
Chimno Ihuoma Nnadi
University Of California, San Francisco
$121,592
Attributed
$121,592
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$121,592 · 1
By mechanism
F30$121,592 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Trever G Bivona$22,714,857
- Eric Collisson$14,159,893
- Robert M Stroud$50,842,733
- Andrej Sali$28,468,790
- Donna M. Ferriero$20,040,301
Others in their field
Other Emerging Leaders on “Acrylamides”
- Maisie Ky Lo · Stanford University$6,822,980
- Liangcai Gu · University Of Washington$2,788,050
- Taylor H Ware · University Of Texas Dallas$2,068,616
- Daniel Alge · Texas Engineering Experiment Station$1,605,517
- Ana Paula Piovezan Fugolin · Oregon Health & Science University$963,049
- Mukesh Kumar Gupta · Vanderbilt University$956,556
Research focus
AcrylamidesAffinityAllelesAffectBindingBiochemicalCell LineCell ModelCellsBaseClinically RelevantClinical PhenotypeCodon NucleotidesComplementComputer SimulationComputer SoftwareCoupledCysteineDesignDeuteriumDisulfidesDockingDrug TargetingEtiology
Grant awards (3)
Development of covalent docking to identify new cysteine-targeted K-Ras inhibitors to address allelic variation in cancer$50,016
F30 · FY2019 · CA · contact PI
Development of covalent docking to identify new cysteine-targeted K-Ras inhibitors to address allelic variation in cancer$36,028
F30 · FY2018 · CA · contact PI
Development of covalent docking to identify new cysteine-targeted K-Ras inhibitors to address allelic variation in cancer$35,548
F30 · FY2017 · CA · contact PI